Press Releases Choose Year All Items 2026 2025 Search Press Releases Found 7 Results October 9, 2026 Quince Therapeutics Relaunches as IRulya Therapeutics with a Focus on the Clinical Development of LAM-001, Targeting a Key Pathway in Pulmonary Disease September 17, 2026 Quince Therapeutics to Host Virtual KOL Event to Discuss the Current Treatment Landscape for PH-ILD and BOS and the Role for LAM-001 as a Potential Therapeutic Option on September 28, 2026 September 3, 2026 Quince Therapeutics to Participate in September 2026 Investor Conferences August 14, 2026 Quince Therapeutics Reports Second Quarter 2026 Financial Results and Corporate Update June 30, 2026 Quince Therapeutics Appoints Recognized Leaders in Pulmonary Medicine to Scientific Advisory Board May 18, 2026 Quince Therapeutics Announces Clinically Meaningful Improvements Across Functional, Hemodynamic and Biomarker Measures in Phase 2 Study in PAH and PH-ILD May 18, 2026 Quince Announces Acquisition of Orphai and up to $187 Million Private Placement to Advance Pulmonary Pipeline
